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As A mEThOd Of dETEcTINg ThE fETAL hEART fAILURE,  
cAUsEd bY PARVOVIRUs b19 INfEcTION
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Background. The article describes the methods and results of investigation of blood flow velocity waveforms 
in fetal ductus venosus (DV). These studies are used to visualize the degree of fetal heart failure and determine 
its further clinical course.
Objective. The study was aimed to predict the development of heart failure in the fetuses that were infected 
with parvovirus B19 infection during 11-14 gestation weeks by measuring the Doppler parameters of blood flow 
velocity in the DV.
Methods. Our investigation involved 20 pregnant women aged from 18 to 30 years old who were infected 
with parvovirus B19 infection during the period from 11 to 14 weeks of gestation. The DV was determined by 
means of color Doppler. Fetal echocardiography (EchoCG) was performed by means of the ultrasound scanner 
Philips HD IIXE device (USA) using a transabdominal convex probe with the frequency of 3.5 MHz, operating in a 
CDC mode and the frequency filter at 100 Hz. The A-wave directivity evaluation in the DV was investigated according 
to the Guideline Principles of the Fetal Medicine Foundation (www.fetalmedicine.com). Statistical processing of 
data was carried out using the package of applied programs Microsoft Office Excel 2016 and Statistica 6, Stata 12.
Results. In 16 of 20 (80%) fetuses we did not observe any absent or reversed A-wave flow in the DV during 
atrial contraction as well as any fetal echocardiographic pathological signs. In 2 (10%) cases a reversed A-wave 
flow in the DV in a combination with EchoCG-signs of overload of left side of heart, resulting in enlargement 
(dilatation) of left atrium and left ventricle were detected. In 2 (10%) cases the presence of a reversed A-wave flow 
in the DV and EchoCG-signs of fetal heart failure (reduction of cardiac output, significant dilatation of left ventricle) 
were evidenced.
The results of the study confirm that with the expansion of fetal nuchal translucency thickness, the systolic 
blood flow velocity in the DV increases with the correlation coefficient r=0.594, which proves a linear dependence 
between these two ultrasonography parameters.
Conclusions. The linear correlation between the presence of a reversed A-wave blood flow velocity in the 
DV and the overload of left side of fetal heart, development of heart failure (20% of the total number of examined 
women) were proved.
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Introduction
Parvovirus B19 infection is a potentially life-
threatening disease [1] for a fetus, especially 
during the first two trimesters of pregnancy 
that can cause a variety of signs of its damage 
(severe anemia, ventriculomegaly, hypertrophic 
myocardiopathy and pericardial effusion, non-
immune fetal hydrops, hydropic or nonhydropic 
intrauterine fetal death, intrauterine growth 
retardation, thrombocytopenia, meconium pe-
ri tonitis, hepatic calcifications, abnormal long­
term neurodevelopment, ascites, placento-
megaly, etc.) [2]. The risk of fetal death depends 
on gestational age in cases of infection. Accor-
ding to gestational age, maternal infection in 
the first trimester leads to fetal death in 19%, 
in 13–20 weeks – 15% and after 20 weeks – 6% 
of cases [3]. It is quite widespread. Approximately 
1–5% of women is susceptible to parvovirus and 
develops serologic evidences during pregnancy 
period; the frequency of morbidity is rising to 
3-34% in epidemic periods; about 50% of 
women have an asymptomatic course of the 
disease [4].
Infection with parvovirus B19 affects many 
organs and systems, mostly cardiovascular 
system. The transmission rate of maternal 
parvovirus B19 infection to fetus is 17% to 33% 
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[5]. Transplacental viral transmission is probably 
explained by the presence in villous trophoblastic 
cells of placental tissues the maximum level of 
neutral glycolipid known as blood group anti-
gen P (globoside), which also serves as a re-
ceptor for B19, during the first two trimesters 
of pregnancy. Cardiomyocytes are the most 
important target cells for parvovirus. P-antigen 
expressed on fetal cardiac myocytes enables 
the virus to infect myocardial cells and induce 
myocarditis that aggravates cardiac failure. 
Fetal heart failure may be caured by severe 
ane mia but may often be associated with myo-
carditis, which can cause arrhythmias or even 
cardiac arrest without evidence of anemia, car-
diac failure or hydrops. Infection within myocar-
dium often results in acute inflammation, but 
may also lead to non­inflammatory damage of 
cells, and as a consequence, to infection-related 
cardiomyopathy. Virus B19 enters the endo-
thelium cells utilizing a globoside and its co-
receptors a5 pi-integrin and Ku80 and after 
connection with a receptor pass to the state of 
persistent infection in the endothelium of 
various organs, including heart. In consequence, 
numerous copies of the viral genome of B19 
are determined in the endothelium of intramyo-
cardial arterioles, capillaries and post-capillary 
venules, initiating inflammation process indu­
ced by the continuous expression of pro-in-
flammatory cytokines (TNF­a, interleukins (IL): 
IL-6, IL-8, IL-2)), IgG, soluble interleukin 2 
receptor, leukotrienes and prostaglandins [6]. 
The direct cytopathic effect of parvovirus, 
apoptosis, activation of innate and adaptive 
immune response lead to endothelial dysfun-
ction, followed by ventricular remodeling and 
development of dilated cardiomyopathy.
The asymptomatic course and late detection 
of parvovirus B19 infection during antenatal 
period are two real problems which may lead 
to the development of cardiac fetal insufficiency.
The advanced ultrasound allows characte-
rizing many complex conditions which are ne-
cessary to evaluate and understanding va rious 
pathologies that contribute to heart failure in 
fetus. Doppler ultrasound tools have improved 
our understanding of fetal circulation and 
patho-physiological mechanism that controls 
fetal circulation. According to the literature, 
ductus venosus (DV) Doppler measurements 
can give information on pregnancy courses, its 
prognosis and can therefore be recommended 
as a part of the routine workup of pregnancies, 
complicated by viral infections, such as par-
vovirus B19.
The article describes the methods and re-
sults of investigation of blood flow velocity 
waveforms in fetal DV. These studies are used 
to visualize the degree of fetal heart failure and 
determine its further clinical course.
The aim of our research was to predict the 
development of heart failure in the fetuses that 
were infected with parvovirus B19 infection 
during 11–14 gestation weeks by measuring 
the Doppler parameters of blood flow velocity 
in the DV.
Methods
20 pregnant women, who were infected 
with parvovirus B19 during the period from 11 
to 14 weeks of gestation, were involved into the 
study. The inclusion criteria were: age from 18 
to 30 years old; singleton pregnancy; absence 
of extragenital pathology events in the sub- and 
decompensation stages; gestation period from 
11 to 14 weeks; no episode of a threatened 
abortion during pregnancy; absence of fetal 
chromosomal abnormalities. The DV was iden-
tified by means of color Doppler. Given that its 
localization at the cephalic end of intraabdominal 
portion of umbilical vein we used two appro-
aches in an oblique transverse and sagittal 
imaging planes through the fetal abdomen to 
visualize the communication between the 
umbilical vein and the inferior vena cava. The 
presence of characteristic high-velocity signals 
in the color Doppler B-mode proved the iden-
tification. Our record was taken in the inlet of 
DV with an insonation ange as near to the long 
axis of the vessel as possible. Blood flow pat­
terns merely proved changes in the pressure 
between the vessel and the right atrium 
throughout the cardiac cycle. After activating 
the color Doppler using a low velocity setting 
(<0.24 m/s), three vessels were detected in 
cross­section: the abdominal aorta, the inferior 
vena, and the DV. Unlike the superior and 
inferior vena cavae in which there may be a 
re verse flow during atrial systole, the flow 
through the DV proves continuous forward flow 
towards the heart. Normal flow in the DV was 
low velocity and triphasic consisting of maximal 
velocities during ventricular systole (S -wave) 
in relation with a rapid filling of the atria; the 
second peak (D-wave) corresponded to the 
early ventricular diastole, and the flow velocity 
was minimal during atrial contraction (A-wave). 
The A-wave directivity evaluation in the DV was 
investigated according to the Guideline Prin-
ciples of the Fetal Medicine Foundation (www.
fetalmedicine.com). The waveforms were clas-
N. P. bondarenko et al.
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sified as normal or abnormal depending on 
whether the A-wave lowest forward velocity 
during atrial contraction in late diastole was 
positive or absent/reversed, respectively. Ab-
sent or reverse A-wave in the DV proved fetal 
cardiac failure. Fetal echocardiography 
(EchoCG) included assessment of the position 
of heart, the four­chamber view, the outflow 
tracts and the venous return to the heart. 
EchoCG was performed by the ultrasound 
scanner Philips HD II XE device (USA) using a 
transabdominal convex probe with the fre-
quency of 3.5 MHz, operating in a CDC mode 
and the frequency filter at 100 Hz. Statistical 
processing of data was carried out using the 
package of applied programs Microsoft Office 
Excel 2016 and Statistica 6, Stata 12. Statistically 
significant differences at p<0.05 were con-
sidered.
Results
Analyzing the results of investigation, in 16 
of 20 (80%) fetuses we didn’t observe any 
absent or reversed A­wave flow in the DV during 
atrial contraction as well as any fetal echocar-
diographic pathological signs of cardiac da-
mage (Fig. 1). In 2 (10%) cases the reversed 
A­wave flow in the DV in a combination with 
EchoCG-signs of overload of left side of heart, 
resulting in enlargement (dilatation) of left 
atrium and left ventricle were detected. In 2 
(10%) cases the presence of reversed A-wave 
flow in the DV and EchoCG­signs of fetal heart 
failure (reduction of cardiac output, significant 
dila tation of left ventricle) were evidenced 
(Fig. 2).
In 20% of the examined women (4 cases) 
with the presence of reversed A-wave blood 
flow velocity in the DV we also made a ma­
thematical correlation between the peak 
systolic blood flow velocity in the DV and the 
fetal nuchal translucency thickness, as one of 
the EchoCG markers of fetal heart failure. The 
findings confirm that with the expansion of 
fetal nuchal translucency thickness there is an 
increased peak systolic blood flow velocity in 
the DV with the correlation coefficient r=0.594 
(the coefficient of determination is R2=0.3534 
with normal range r=0.161 (R2=0.0258)) that 
proves a linear dependence between these two 
ultrasonography parameters (Fig. 3): the 
coefficient of determination is the percentage 
of response variable variation that is explained 
by a linear model (dependence on the changes 
of one parameter from another in percenta-
ges) – in our case 0,3534 (35,34%) which means, 
that the peak systolic blood flow velocity 
changes in the DV 35.34% depends on changes 
in the fetal nuchal translucency thickness and 
could predict the future fetal cardiac compro-
mise (p<0.05).
Discussion
Dynamic observation of gestational process 
allows relate some features of ultrasound 
pattern evidenced in 11–14-week fetuses with 
an increased risk of heart failure development. 
Parvovirus B19 infects primarily the erythroid 
cell line and may therefore cause fetal anemia 
and consequently cardiac failure with hydrops 
fetalis in some cases. Doppler measurement 
technics today can modify treatment so that 
the number of fetuses infected with virus B19 
and its attendant risks can be minimized, 
without missing the opportunity for timely, life-
saving intervention when it is warranted.
Fig. 1 (leftward). Normal blood flow velocity measured in 
the ductus venosus during 12 gestation weeks in the 
woman infected with parvovirus B19
Fig. 2 (rightward). Reversed A­wave flow waveform in the 
ductus venosus during 12-13 gestation weeks measured 
in the woman infected with parvovirus B19
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Increased fetal nuchal translucency thick-
ness was established to be a myocardial 
dysfunction and/or fetal anemia [7]. The cor-
relation between the increased nuchal trans-
lucency and the presence of abnormal blood 
flow profile in the DV was proved. The measu­
rement of peak systolic blood flow velocity in 
the DV is the latest tool of non-invasive 
monitoring of fetuses at risk for anemia and 
cardiac insufficiency due to parvovirus B19. In 
the article, the increased fetal nuchal trans-
lucency thickness was found with reversed flow 
in the DV during atrial contraction, this findings 
were helpful indicators of the presence of fetal 
heart failure.
In summary, the linear correlation between 
the presence of a reversed A­wave blood flow 
velocity in the DV and the overload of left fetal 
heart, the development of heart failure (20% of 
the total number of examined women) was 
proved.
Conclusions
Parvovirus B19 infection has a direct patho-
logical effect on the endothelium of intra myo-
cardial arterioles, capillaries and post-capillary 
venules. The development of dilated cardio-
myopathy and heart failure are two pathological 
consequences of B19 cardiac damage.
The most reliable way to diagnose fetal 
heart failure during antenatal period is the 
Doppler and EchoCG investigation of blood flow 
velocity waveform in the DV and the measu-
rement of nuchal translucency thickness.
In case of left-sided heart insufficiency 
occur the volume overload of right side of fetal 
heart with increased pressure in the DV, the 
presence of a reversed A­wave flow velocity in 
the DV and increased peak systolic blood flow, 
the expansion of fetal nuchal translucency 
thickness and decreasing left ventricular 
isovolumic relaxation time.
A linear relationship between the increased 
fetal nuchal translucency thickness and the 
peak systolic blood flow velocity in the DV was 
determined.
According to the results of the study, we can 
conclude that there is a direct correlation 
between the appearance of a reversed A-wave 
blood flow in the DV and the development of 
fetal heart failure.
Fig. 3. Correlation curve between the peak systolic blood 
flow velocity in the ductus venosus (cm/s) and fetal nuchal 
translucency thickness (mm)
gestation weeks in the woman infected with parvovirus B19
Figure 2 (rightward). Reversed A-wave flow waveform in the ductus venosus during 12-
13 gestation weeks measured in the woman infected with parvovirus B19
In 20% of the examined women (4 cases) with the presence of reversed A-wave blood flow 
velocity in the DV we also made a mathematical correlation between the peak systolic blood flow 
velocity in the DV and the fetal nuchal translucency thickness, as one of the EchoCG markers of 
fetal heart failure. The findings confirm that with the expansion of fetal nuchal translucency 
thickness there is an increased peak systolic blood flow velocity in the DV with the correlation 
coefficient r=0.594 (the coefficient of determination is R2=0.3534 with normal range r=0.161
(R2=0.0258)) that proves a linear dependence between these two ultrasonography parameters (Fig.
2): the coefficient of determination is the percentage of response variable variation that is 
explained by a linear model (dependence on the changes of one parameter from another in 
percentages) – in our case 0,3534 (35,34%) which means, that the peak systolic blood flow 
velocity changes in the DV 35.34% depends on changes in the fetal nuchal translucency thickness 
and could predict the future fetal cardiac compromise (p<0.05). 
Fetal nuchal translucency thickness (mm)
 Normal PSV ■  Patology PSV
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